STATE STREET CORP

Position in INBX — Inhibrx Biosciences, Inc.

CIK 93751 BOSTON, MA

Position in INBX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$37,033,309

+$7,411,390 QoQ

Shares Held

550,845

+46.9% QoQ

Ownership

3.75%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 9.372327968847861.ToString("F0")% Shared 0.ToString("F0")% None 90.62767203115214.ToString("F0")%

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $30,293,175,602 across 421 Biotechnology names. INBX ranks #113 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	11,730,139	$5,237,976,269
2	REGN	Regeneron Pharmaceuticals, Inc.	4,664,478	$3,603,962,281
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,322,698	$1,099,381,087
4	INSM	INSMED Inc	5,551,699	$907,813,820
5	INCY	Incyte Corp	9,641,384	$907,447,062
6	MRNA	Moderna, Inc.	14,861,409	$754,959,577
7	RPRX	Royalty Pharma plc	10,989,851	$527,183,152
8	ROIV	Roivant Sciences Ltd.	16,186,613	$448,369,180

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$37,033,309	550,845	+46.9%	Shares	Defined	2026-05-15
2025-12-31	$29,621,919	374,961	+83.9%	Shares	Defined	2026-02-13
2025-09-30	$6,868,126	203,923	-0.5%	Shares	Defined	2025-11-14
2025-06-30	$2,924,764	204,959	+18.5%	Shares	Defined	2025-08-14
2025-03-31	$2,418,926	172,904	-2.0%	Shares	Defined	2025-05-15
2024-12-31	$2,716,205	176,377	+10.1%	Shares	Defined	2025-02-14
2024-09-30	$2,508,403	160,179	+7.8%	Shares	Defined	2024-11-14
2024-06-30	$2,105,463	148,586	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.